Learning resources for mRNA production in development of mRNA therapeutics and vaccines

Browse through our curated selection of learning resources to enable your success in development of mRNA therapeutics and vaccines. View available technical assets related to raw materials for mRNA production, process development using in vitro transcription, scale-up synthesis of mRNA, and more. Find the information and resources you need by looking through our scientific content below.

View content by category

Case studies	eBooks	Infographics	Posters
Technical notes	Videos	Webinars

Case studies

Manufacturing personnel operating a bioreactor

Scaling up raw material manufacturing for mRNA production

In ~10 months, Thermo Fisher Scientific drastically scaled up raw material manufacturing for mRNA production, from concept to clinical development and on to industrial-scale production.

Manufacturing room with a row of bioreactors

Breaking new ground on animal origin–free reagents

Thermo Fisher Scientific quickly developed and executed manufacturing processes to deliver animal origin–free (AOF) enzymes at scale to a biopharmaceutical client.

eBooks

Making the promise of mRNA a reality: overcoming scale-up challenges

Read about the prospects of the mRNA technology, tips on scaling up mRNA production, and analytical solutions for mRNA vaccines and therapeutics.

Riding the mRNA highway

Read about expert views on mRNA development and manufacturing, advantages of mRNA processes, and best practices for scale up of in vitro transcription for mRNA production.

Infographics

RNA production components and a bioreactor

Accelerating development and manufacturing of mRNA vaccines and therapeutics—why raw materials matter

Review the mRNA production process and some critical considerations for choosing raw materials to support clinical manufacturing efforts.

Computer screen with a rising graph and a lightbulb

Beyond GMP grade—how to ensure more robust development and manufacturing processes

Understand how your processes and material usage strategy during the development phase could impact your manufacturing processes and regulatory approval downstream.

Scaling mRNA vaccine production

Enable agility in your process from vaccine development to manufacture with one technology designed for flexible mRNA synthesis and purification.

Posters

mRNA yield graph with buffer and pH conditions

Determination of the optimal buffer conditions and nucleotide concentrations to maximize mRNA yield using in vitro transcription

By using design of experiments (DoE) principles and analytics, a variety of IVT reaction conditions were assessed for their impact on the IVT reactions.

Single-use–based bioproduction process for manufacturing of high-quality recombinant enzymes for mRNA and DNA workflows

A closed system based on single-use technology was used to drastically minimize the risk of contamination inherent to the conventional manufacturing process of IVT enzymes.

A trinucleotide cap analog bearing a locked nucleic acid moiety: synthesis, mRNA modification, and translation for therapeutic applications

A new cap analog was synthesized and evaluated for its translational performance against the standard trinucleotide cap and anti-reverse cap analog.

White papers

N1-methylpseudouridine triphosphate structure

Quality and consistency of N1-methylpseudouridine triphosphate

Read about an analysis of some of the key product quality attributes of a modified nucleotide product, and their impact on the development and manufacturing of a therapeutic.

Impurity profiling and analysis of TheraPure GMP nucleotides

Read about the importance of quality of nucleoside triphosphates (NTPs) that are used for the production of mRNA therapeutics.

Videos

Webinars

Learning Resources for mRNA Production